Coronavirus | Opeds and editorials

Rein in the vaccine nationalism, the profiteering

It is illegal to hoard, for black marketing, essential goods in drought-affected areas. Overcharging of commodities and services during any natural disaster is always a scandal. It is a crime against humanity to make a profit during any human tragedy. On the contrary, there is (and should be) empathy and concern about human suffering. Such solidarity is a recognition of the need to: prevent further damage and destruction, rescue and evacuate affected people to safer zones, and salvage belongings and meet their minimal survival needs. For this nobody is charged. Instead, it is considered as relief work which comes out profusely as charity; a humane gesture.

Business out of suffering

The COVID-19 pandemic is also a human tragedy and needs global solidarity. It is definitely not a time to be doing business and making a fast buck. Making enormous profit out of a human tragedy is shameful. Unfortunately, such a sense of shame is missing in the international trade market. When economies crumbled in many countries, e-commerce and gadget-based gaming business boomed. And in the novel coronavirus pandemic, there are numerous examples of companies having made enormous profits in the supply of personal protective equipment and kits and ventilators.

Coronavirus | WHO chief scientist warns against ‘vaccine nationalism’

In a liberalised economy, there is a shocking silence in the global market trying to do business out of human suffering. Business lies in selling technologies around COVID-19, the diagnostics, drugs and vaccine candidates. This is where organisations of the United Nations and global networks for people should come together in one voice. The World Health Assembly, in May 2020, in cognisance of the obstacles to equitable access to COVID-19 technologies such as vaccines, diagnostics, medicines, PPE kits and machines, set up mechanisms to counter it. When the entire global population, estimated to be nearly eight billion people, is in need of a vaccine (still being tested and yet to be approved) then production at full capacity and supply to every country will take time.

Mechanisms that can help

We cannot allow the rich and the strong to grab everything first. The advance purchase agreements that some countries have negotiated with pharmaceutical companies exemplify such adverse trends. Such vaccine nationalism undermines equitable access to vaccines. There has to be prioritisation for high-risk groups in all countries, especially in the least developed, low- and middle-income nations. That framework has to be accepted by the global community without dispute. In this, the COVAX partnership is a mechanism for ensuring that.

GAVI, or the Global Alliance for Vaccine Initiative, was in existence during the pre-COVID-19 period to ensure the pooled procurement and equitable supply of life-saving vaccines to low- and middle-income countries. It has been roped in for the COVID-19 vaccine too.

Comment | More than a vaccine, it is about vaccination

Dr. Tedros Adhanom Ghebreyesus, the World Health Organization Director General, on June 13, exhorted member countries to treat COVID-19 technologies as a “public good”. Obviously it fell on deaf ears as far as pharmaceutical companies were concerned. WHO’s idea of a “voluntary pool to collect patent rights, regulatory test data, and other information that could be shared for developing COVID-19 therapies, vaccines, and diagnostics” was met with criticism. The CEO of Pfizer even qualified this as, “... I think it’s nonsense, and… it’s also dangerous.”

Governments have a part

A public good is a common property of the nation and such goods are not excludable or there should not be any rivalries in dealing with it. If it is a public good, governments must step in to regulate its development, innovation, manufacture, sale, and supply ultimately to the public. If there is public financing for technology development, there is no scope for grant of patent protection. A public good cannot be submitted to the vagaries of market fluctuations of pricing dependent on demand-supply dynamics. Governments should be the custodian of public goods.

Comment | Vaccines with a global common good guarantee

If such an idealistic outcome does not materialise based on basic human rights for availability of accessible and affordable health care, then some regulation mandated by the UN General Assembly must be thought of.

The World Trade Organisation (WTO) had raised concern over public health with regard to the non-availability of patented drugs in sufficient quantity, and at affordable prices. Through the Paris Convention for the Protection of Industrial Property, the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the Doha Ministerial Conference declaration 2001, the WTO made provisions for compulsory licensing. This is a provision where the government intervenes when patent clauses regarding availability, reasonable pricing, local production and technology transfer are not met by the patent holder. Compulsory licensing is an “involuntary contract” issued by the national government between a “willing buyer” or local manufacturer and an “unwilling seller” or patent holder foreign company. Thailand and Brazil have done this. India utilised this provision for the first time on March 9, 2012 to grant licence to Natco Pharma Hyderabad against the will of patent owner Bayer, Germany, to manufacture Sorafenib tosylate, a life-saving anti-cancer drug for kidney and liver tumours, with 97% cost reduction. It is sold by Bayer under the brand name, Nexavar. This is an extreme step available with India if rich countries go for advance purchase and hoarding of a COVID-19 vaccine produced in India by multinational pharma companies and deny India’s supply needs.

Also read | Serum Institute of India to focus on supplying COVID-19 vaccine to India first

COVID-19 vaccine candidates are still in Phase 3 trials; regulatory approval and patent are still awaited. So, failure to comply with patent regulations as a reason for the issue of compulsory licence cannot be applied. Coercion to issue “voluntary licensing” to subsidiary companies in many developing countries such as India, Egypt, Thailand and Brazil by the patent holder is another option.

A chance to act

Seizing the opportunity of the WTO itself mapping out key trade issues arising out of COVID-19 vaccine and fostering dialogue, India and South Africa jointly sent out a communication, on October 2, 2020 to the IPR Council of the WTO for a waiver of the protection of copyright, design, trademarks and patent on COVID-19 related technologies including vaccines. It is claimed that India’s submission has the support of 43 members of the African group and 36 members of Least Developed countries group apart from South Asian Association for Regional Cooperation countries, Indonesia, Venezuela and Nicaragua. If this is decided favourably as a special case considering the unprecedented impact of the pandemic, it will set a precedent. A UN organisation such as the WTO can wield influence on member-nations to forgo trade profits for a humanitarian cause. Global campaigns through the media and civil society organisations can garner enough momentum to exert pressure on TRIPS. This is a pragmatic step for the time being. But having nothing less than vaccines and life-saving medicines being treated as a public good must definitely be the long-term goal.

Dr. K.R. Antony is a public health consultant at Kochi and an independent monitor for the National Health Mission. The views expressed are personal

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Jan 17, 2021 3:23:55 AM | https://www.thehindu.com/opinion/lead/rein-in-the-vaccine-nationalism-the-profiteering/article33187909.ece

In This Package
Vaccine optimism and the scientific uncertainty link
Building trust in vaccines
The debilitating side-effect of a flawed vaccine trial
Gearing up: On vaccines and public trust
A hurried gamble: On vaccines and transparency
The second dose: On COVID-19 vaccine
A constant vigil: On the new coronavirus strain in India
Unmasked, reflections on the pandemic and life
Caution pays: On Centre’s COVID-19 surveillance guidelines
Towards an effective vaccination distribution policy
Essential dry run: On COVID-19 vaccination drive
COVID-19 and limits of political accountability
The purpose of a vaccine
Clear the fog, draw up a clear vaccination policy
You are reading
Rein in the vaccine nationalism, the profiteering
In vaccine race last lap, the key steps for India
The storage tale of two vaccines
T-cell immunity and COVID-19
COVID-19, climate and carbon neutrality
Signs of easing: On India’s COVID-19 fight
Has India passed the COVID-19 peak?
Sooner, better: On indigenously developed COVID-19 test kits
The battered Puja economy
Outline of a pandemic fight, by and for citizens
Pandemics and the collective consciousness
Vaccines with a global common good guarantee
Saving lives under the long shadow of the pandemic
Until vaccine: On Unlock 5
The challenge of changing health behaviour
Weighing the costs: On COVID-19 vaccine
The slow and frustrating journey of recovering from COVID-19
Health worker safety deserves a second look
Unlocking campuses: On UGC’s revised academic calendar
Recovery from COVID-19 can be a struggle
Uniting to combat COVID-19
Coronavirus fears and preconception advice
An agriculture-led revival as flawed claim
A necessary pause: On the COVID-19 vaccine race
The uncertainties over COVID-19 numbers
The challenges in counting the dead
COVID-19 deaths may be higher than reported
The many challenges in estimating deaths
Alone at the top: On India’s COVID-19 numbers
The participants we need in Phase 3 trials
Differential impact of COVID-19 and the lockdown
More than a vaccine, it is about vaccination
COVID-19 and a country club India must leave
A quest for order amid cyber insecurity
Adopting a public systems approach to COVID-19
Milestone of a million: On India’s COVID-19 numbers
Testing times: On university exams
Predictions, pandemics and public health
It’s time to flatten the pandemic stereotyping
Viral outrage only spikes the data
Sending the right message
Needed: Clear testing data
The social contract needs to be rewritten
The pandemic is about eyes shut
Joblessness and opportunity in Tamil Nadu
Green-lighting ecological decimation amidst a pandemic
COVID-19 has no religion
A case for extension: On rural jobs scheme
Surely, even if slowly: On a COVID-19 vaccine
Bend it like Italy: On flattening the COVID-19 curve
Promise and delivery: On India’s first COVID-19 vaccine
States hold the key: On Unlock 2.0
PCR testing is a double-edged sword
Science vs nonsense: On Patanjali’s COVID-19 claim
Shut and open: On tennis during the pandemic
The perils of follow the leader syndrome
The many questions about Favipiravir
In new lockdown, a second chance for Tamil Nadu
United front in Delhi: On Kejriwal government-Centre camaraderie
A prescription of equitable and effective care
Multilateralism post COVID-19
Making public transport safe during COVID-19
A better rate: On COVID-19 recovery
Look back in relief: On the migrant labour crisis
Needed, a transfusion for public health care
Wrong priorities: On keeping religious places open during a pandemic
Crossing the line: On Delhi’s decision to limit health services
Profit, not profiteering: On regulation of COVID-19 testing charges
In Persian Gulf littoral, cooperative security is key
Paging the private sector in the COVID fight
Curves and recoveries: On India’s coronavirus numbers
India’s Parliament is missing in action
Axing the economy’s trunk
Scripting a new narrative for COVID control
Open with caution: On Unlock 1
It’s time for a universal basic income programme in India
The waning of subaltern solidarity for Hindutva
Export blocks: On India’s trade amid the pandemic
A moment to trust the teacher
The echo of migrant footfalls and the silence on policy
Enjoying the fruits of their labour
Helping supply chains recover
The heavy burden of social suffering
An effective lockdown
The lockdown has highlighted stark inequalities
Will sport be the same in empty stadia?
Cinema after COVID-19
The eternal longing for the distant home
Working safely: On workplaces during the pandemic
A hole in the whole: On health sector woes
China, better prepared for the post-COVID world
How public health boosts an economy
Keep it retrospective
Backing the ‘angels in white coats’
Standstill: On opening of stadia for training
Flawed stimulus is justice denied
We need social physicians
A callous response
Peaking: On India’s coronavirus tally
Farm gate in focus: On amending Essential Commodities Act
A question of quarantine: On migrant workers and other travellers
TASMAC tribulations: On Tamil Nadu liquor sale
The pandemic and the challenge of behaviour change
One for the poor: On Centre’s corona package
Lockdown syndrome: On virus-induced economic crisis
Are India’s labour laws too restrictive?
Stop the return to laissez-faire
States cannot be left to the Centre’s mercy
Local motif: On Modi’s call for self-reliance
Liquidity lifeline: On Nirmala’s MSME package
A plan to revive a broken economy
Provide income support, restore jobs
Perilous state: On State finances
COVID-19 and the path ahead
Reaffirm cooperative federalism
Riding roughshod over State governments
Tragedy on the tracks: On the killing of 16 migrant workers
Coming to terms: On India refusing to admit community transmission
The trends shaping the post-COVID-19 world
The epidemic and ensuring safety in courts
Responding to COVID-19 at the grassroots
The face of exploitation
Contempt for labour: On dilution of labour laws
Slower growth and a tighter fiscal
Back home: On return of Indian expatriates
Blame game: On Donald Trump’s anti-China rhetoric over COVID-19
Resuscitating multilateralism with India’s help
A war-like state and a bond to the rescue
Fear and loathing in the land of the free
Everyone wants a good stimulus
Rent control amidst pandemic
Slow release: On lockdown 3.0
No comfort in numbers: On Bengal’s coronavirus cases
Pandemics without borders, South Asia’s evolution
India’s disease surveillance system needs a reboot
No relief for the nowhere people
BRICS against COVID-19
Recovering early: On India’s COVID-19 patients
It’s about food, nutrition and livelihood security
Taiwan’s coronavirus protocol shows how it is done
Needed: a pandemic patent pool
Getty Images/iStockphoto
Plasma therapy is no silver bullet
Take care of yourself too, fellow journalists
Strategic shift: On home isolation of mild coronavirus cases
Coping with today, planning for tomorrow
No end in sight: On India’s coronavirus strategy
Vividly imagining the life of migrant workers
A task for South Asia
Privacy concerns during a pandemic
Unlocking justice in the lockdown
Safe return: On migrant worker distress
The outline of another pandemic combat strategy
Pandemic and panic: On Tamil Nadu’s five-city lockdown
Protecting the poor from becoming poorer
Did SARS-CoV-2 begin from a lab?
Protection for protectors: On safety of healthcare workers
Rapid failures: On antibody testing kits
The COVID-19 paradox in South Asia
Fishing in troubled waters during a pandemic
How will India emerge out of the lockdown?
Making doctors wash hands
Locked out of cities, homes and livelihoods
Script of unity: On coronavirus and social prejudices
Exploiting a pandemic: On Trump’s immigration policy
The village is still relevant
A time for planetary solidarity
There may be no going back
No transparency in West Bengal
Focus on the curve: On India’s COVID-19 numbers
Economy in lockdown: On India’s worst case scenario
A shot of hope with a game changing vaccine
Caught in the heightened arc of communal polemics
Singing the corona tune
Helping a lending hand: On RBI’s second lockdown stimulus
A season of change: On IMD forecast system
A virus, social democracy, and dividends for Kerala
Across the gulf: On stranded Indian workers
Virtual reality: On telemedicine
A blueprint to revive the economy
A case to use JEE-Main instead of JEE-Advanced this year
Will the aviation industry recover from the pandemic?
Data-driven reporting during COVID-19
Stress test: On revised lockdown guidelines
Disastrous decision: On Trump halting funds to WHO
Cease the distractions, seize the moment
Getting the containment strategy in India right
In India’s response, a communications failure
Harmonising with nature
End the harassment of farmers now
A narrowing window: On extension of lockdown
Corona bond: On Eurozone COVID-19 rescue package
Halting the march of rumours
Polls during a pandemic
The pandemic and the contours of a health response
Economic liberalisation and its faults
Invasive, alien, most fearsome
Trade in tatters: On the global slump
Wanted, a collective national endeavour
Disingenuous and no antidote
COVID-19 and the crumbling world order
Women’s safety during lockdown
Lives and livelihoods: On economy after lockdown
Stage fright: On denying community transmission
Team India and winning the pandemic battle
In time of need: On hydroxychloroquine export
Will COVID-19 affect the course of globalisation?
Finding a scapegoat in WHO
Curating news for children during pandemic
A time for extraordinary action
For better use: On MPLADS funds
Needed, greater decentralisation of power
A key arsenal in rural India’s pandemic fight
Preparing for exit: On lifting the lockdown
Sanctions and pandemic: On America’s Iran policy
‘A script of action, responsibility and compassion’: Chief Minister Ashok Gehlot writes on Rajasthan’s fight against COVID-19
Taking a long view of the pandemic fight
Ten questions posed by the virus
A different economic approach
Why healthcare workers above 60 should be ‘benched’
Enemy at the gates: On Kerala-Karnataka border row
Reducing farm distress during a pandemic
Why everyone should wear masks
The criticality of community engagement
A niggardliness that is economically unwarranted
The spectre of a post-COVID-19 world
Light and sound: On Narendra Modi’s 9-minute light ceremony
A million and counting: On global coronavirus spread
Safe forests, safe people: On diseases of animal origin
Quarantine and the law
Making the private sector care for public health
Looking east to contain COVID-19
Limits to rugged individualism
Uncritical endorsement: On exodus of migrant workers and the Supreme Court
Beyond the blame game: On the Tablighi Jamaat episode
A long road: On India’s 21-day coronavirus lockdown
The missing notes: On politics and the fight against COVID-19
China’s zero: On China’s lead in containing coronavirus
Unprecedented step: On Wuhan lockdown
The return of the expert
Lessons from Hubei
A pandemic in an unequal India
Faith can’t override public health
Devising a people-centric response to COVID-19
Karnataka CM writes on how the State is fighting the pandemic
Tamil Nadu CM writes on how the State is stopping the pandemic in its tracks
The hunt for a cure begins with telling the truth
COVID-19 and a city’s anatomy
Long live the nation-state
The COVID cycle
Coronavirus | The worst of times, the best of times
It’s also a fight against punitive measures
The age of the neoliberal virus
The deep void in global leadership
Thinking national, acting local
Every man is a part of the main
Beyond social distancing to fight COVID-19
Next Story